TW200738231A - Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine - Google Patents
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraineInfo
- Publication number
- TW200738231A TW200738231A TW096105363A TW96105363A TW200738231A TW 200738231 A TW200738231 A TW 200738231A TW 096105363 A TW096105363 A TW 096105363A TW 96105363 A TW96105363 A TW 96105363A TW 200738231 A TW200738231 A TW 200738231A
- Authority
- TW
- Taiwan
- Prior art keywords
- migraine
- treatment
- benzo
- fused heterocycle
- sulfamide derivatives
- Prior art date
Links
- 208000019695 Migraine disease Diseases 0.000 title abstract 3
- 206010027599 migraine Diseases 0.000 title abstract 3
- -1 heterocycle sulfamide derivatives Chemical class 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 229940125684 antimigraine agent Drugs 0.000 abstract 1
- 239000002282 antimigraine agent Substances 0.000 abstract 1
- 238000011262 co‐therapy Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention is the use of a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as herein defined for the manufacture of medicaments for the treatment or prevention of migraine. The present invention is directed to the use for the treatment and / or prevention of migraine, which includes mono-therapy and alternatively, co-therapy with at least anti-migraine agent.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77376406P | 2006-02-15 | 2006-02-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200738231A true TW200738231A (en) | 2007-10-16 |
| TWI404528B TWI404528B (en) | 2013-08-11 |
Family
ID=38813279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW96105363A TWI404528B (en) | 2006-02-15 | 2007-02-14 | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR059503A1 (en) |
| PE (1) | PE20080108A1 (en) |
| TW (1) | TWI404528B (en) |
| UY (1) | UY30160A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849635B2 (en) * | 2001-05-07 | 2005-02-01 | Smithkline Beecham Corporation | Sulfonamides |
| TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
-
2007
- 2007-02-14 TW TW96105363A patent/TWI404528B/en not_active IP Right Cessation
- 2007-02-14 PE PE2007000164A patent/PE20080108A1/en not_active Application Discontinuation
- 2007-02-14 UY UY30160A patent/UY30160A1/en unknown
- 2007-02-14 AR ARP070100630 patent/AR059503A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20080108A1 (en) | 2008-02-11 |
| TWI404528B (en) | 2013-08-11 |
| UY30160A1 (en) | 2007-07-31 |
| AR059503A1 (en) | 2008-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007095618A3 (en) | Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine | |
| IL192103A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression | |
| EA200601746A1 (en) | APPLICATION OF ROTIGOTINE FOR THE TREATMENT AND PREVENTION OF THE PARKINSONISM-PLUS SYNDROME | |
| IL192181A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
| TW201000473A (en) | Benzene or thiophene derivative and use thereof as VAP-1 inhibitor | |
| MX2011011854A (en) | Dihydropyrimidinones for use as bace2 inhibitors. | |
| IL192100A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
| MX2010008460A (en) | Thiazole derivative and use thereof as vap-1 inhibitor. | |
| TW200738651A (en) | Cyclohexyl sulfonamide derivatives | |
| WO2007048801A3 (en) | Sexual desire enhancing medicaments comprising benzimidazolone derivatives | |
| UA95103C2 (en) | Substituted arylsulfonamides as antiviral agents | |
| TN2011000204A1 (en) | Cycloundecadepsipeptide compounds and use of said compounds as a medicament | |
| MX2009004770A (en) | Carbamate compounds for use in treating depression. | |
| TW200740429A (en) | Methods and dosage forms for reducing side effects of carbamate compounds | |
| MY145823A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity | |
| JO2999B1 (en) | Tricyclic Compound And Pharmaceutical Use Therof | |
| NO20083901L (en) | Fixed-dose association of phytate and zinc | |
| MX2009005516A (en) | Urea and sulfamide derivatives as tafia inhibitors. | |
| WO2007095611A3 (en) | Use of benzo-fused heteroaryl sulfamide derivatives for the treatment of migraine | |
| TW200738231A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine | |
| WO2008131859A3 (en) | Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia | |
| WO2007115020A3 (en) | Therapeutic prostaglandin compounds for the treatment of glaucoma | |
| TW200735880A (en) | Medicinal compositions for preventing or treating heart failure | |
| TW200744580A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
| UA100552C2 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety and related disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |